TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16856945

Group type: EXPERIMENTAL
Intervention: Incentives on response rates in a school-based dental study
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional methods for correlated binary data
Number of subjects: 0
Study: 12704501

Group type: EXPERIMENTAL
Intervention: Vitamin E coated dialyzer (CL‐EE12, Terumo)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Fresenius 60 (F60) dialyzer
Number of subjects: 75
Study: 10561342

Group type: EXPERIMENTAL
Intervention: Twice-daily thoracic irradiation (TDTI)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Once-daily thoracic irradiation (ODTI)
Number of subjects: 311
Study: 9522755

Group type: EXPERIMENTAL
Intervention: Maisto's paste
Number of subjects: 30

Group type: COMPARATOR
Intervention: Zinc oxide-eugenol
Number of subjects: 30
Study: 1928770

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia in combination with light general anesthesia (group 2)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Balanced general anesthesia (group 1)
Number of subjects: 173
Study: 6811195

Group type: EXPERIMENTAL
Intervention: Copper-releasing IUD
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing IUD (30 micrograms/day)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Levonorgestrel-releasing IUD
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing IUD (10 micrograms/day)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both IUDs
Number of subjects: 110
Study: 31972694

Group type: EXPERIMENTAL
Intervention: Immersive VR training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (traditional learning using a technical journal article)
Number of subjects: 19
Study: 31254177

Group type: EXPERIMENTAL
Intervention: Related neutral pictures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unrelated neutral pictures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed condition (distinct processing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unmixed condition (nondistinctive processing)
Number of subjects: 0
Study: 29240005

Group type: EXPERIMENTAL
Intervention: Dual-ring wound protector
Number of subjects: 107

Group type: COMPARATOR
Intervention: No wound protector (control)
Number of subjects: 107
Study: 27152849

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (CBT) guided by a clinician for 8 weeks, comprising 8 modules of written text.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waiting list control group (no intervention).
Number of subjects: 56
Study: 24748154

Group type: EXPERIMENTAL
Intervention: Wound-edge protection devices (WEPDs)
Number of subjects: 735

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 735
Study: 22056369

Group type: EXPERIMENTAL
Intervention: Awake nonresectional lung volume reduction surgery
Number of subjects: 63
Study: 20705153

Group type: EXPERIMENTAL
Intervention: Estradiol vaginal ring for 3 months
Number of subjects: 71

Group type: COMPARATOR
Intervention: DMPA alone
Number of subjects: 71
Study: 17912164

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 0
Study: 16294814

Group type: EXPERIMENTAL
Intervention: Inotropics + intra-aortic balloon pump
Number of subjects: 40

Group type: COMPARATOR
Intervention: Inotropics
Number of subjects: 40
Study: 12045167

Group type: EXPERIMENTAL
Intervention: Allopurinol 600 microg/min
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg/d
Number of subjects: 19
Study: 10073079

Group type: EXPERIMENTAL
Intervention: Hartmann's solution preloading (500 ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No preloading
Number of subjects: 40
Study: 7727602

Group type: EXPERIMENTAL
Intervention: Erythropoietin 200 IU/kg/day with ferric pyrophosphate 40 mg/day intravenously for 7 days before and 14 days after operation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ferric pyrophosphate 40 mg/day alone (control group)
Number of subjects: 10
Study: 2024581

Group type: EXPERIMENTAL
Intervention: Fluorouracil-levamisole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorouracil-leucovorin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy and postoperative radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorouracil (alone or combined with leucovorin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy alone
Number of subjects: 0
Study: 7238993

Group type: EXPERIMENTAL
Intervention: Betadine Vaginal Cleansing Kit
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no cleansing agent)
Number of subjects: 24
Study: 31997087

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 58
Study: 29529858

Group type: EXPERIMENTAL
Intervention: Irinotecan plus cisplatin (IP)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Etoposide plus cisplatin (EP)
Number of subjects: 362
Study: 28272230

Group type: EXPERIMENTAL
Intervention: TaperGuard ETT
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cylindrical ETT
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 26512604

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.125%
Number of subjects: 481

Group type: COMPARATOR
Intervention: Combination of 0.125% ropivacaine + 0.3 μg/mL sufentanil
Number of subjects: 481

Group type: COMPARATOR
Intervention: Sole local anesthetic group
Number of subjects: 481
Study: 24095220

Group type: EXPERIMENTAL
Intervention: Capecitabine (C) plus Docetaxel (D)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Docetaxel (D) alone
Number of subjects: 506
Study: 22011054

Group type: EXPERIMENTAL
Intervention: DVD-based seated dual-task stepping exercise
Number of subjects: 93

Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 93
Study: 19656525

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 130

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 130
Study: 17566313

Group type: EXPERIMENTAL
Intervention: Trandolapril (4 mg)
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Verapamil-SR (240 mg)
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Trandolapril (4 mg) + Verapamil-SR (240 mg) combination
Number of subjects: 631

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study: 12911367

Group type: COMPARATOR
Intervention: Diazepam 0.1 mg.kg‐1
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Diazepam (various doses: 0, 0.025, 0.5, 0.1, 0.175 mg.kg‐1)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Diazepam (0.1 mg.kg‐1)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Lower diazepam doses
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Higher diazepam doses
Number of subjects: 400
Study: 11138599

Group type: EXPERIMENTAL
Intervention: Rofecoxib (Vioxx)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib (Celebrex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional NSAIDs (diclofenac, ibuprofen, naproxen)
Number of subjects: 0
Study: 8815995

Group type: EXPERIMENTAL
Intervention: Multimodal treatment (A) consisting of postural training, manual technique, and psychological support
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control treatment (B) using physical agents only (electrical and sonic modalities)
Number of subjects: 60
Study: 1357553

Group type: EXPERIMENTAL
Intervention: Corticosteroid group (beclomethasone, 800 micrograms daily)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Anticholinergic group (ipratropium bromide, 160 micrograms daily)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 274
Study: 4074611

Group type: EXPERIMENTAL
Intervention: Ultrasound administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no ultrasound)
Number of subjects: 0
Study: 2887192

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ, 25 mg day‐1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pindolol (PIND, 10 mg day‐1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of HCTZ and PIND
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29906734

Group type: EXPERIMENTAL
Intervention: Fully weight-based dosing of chemotherapy (LV5FU2)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Dose-reduced chemotherapy
Number of subjects: 280
Study: 28409365

Group type: EXPERIMENTAL
Intervention: Troubleshooting checklist during second trial
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 20
Study: 26246032

Group type: EXPERIMENTAL
Intervention: Kenya Cash Transfer for Orphans and Vulnerable Children
Number of subjects: 1549

Group type: COMPARATOR
Intervention: Control group (delayed entry to the program)
Number of subjects: 1549
Study: 24138766

Group type: EXPERIMENTAL
Intervention: Active screening for tuberculosis (symptom screening, examination, and chest radiography on four occasions over a two-year period)
Number of subjects: 8829

Group type: EXPERIMENTAL
Intervention: Active screening for tuberculosis
Number of subjects: 8829

Group type: COMPARATOR
Intervention: Control group (no active screening)
Number of subjects: 8829
Study: 21119149

Group type: EXPERIMENTAL
Intervention: Regular recommendation role (antidepressant for depression, depot for schizophrenia)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: What would you do if you were me, doctor?
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Self role (treatment chosen for themselves)
Number of subjects: 515
Study: 18830096

Group type: EXPERIMENTAL
Intervention: Iomeprol 400 (90 mL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iomeprol 300 (120 mL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Iomeprol 400
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 40
Study: 17015530

Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation plus pressure support
Number of subjects: 107

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation plus pressure support (700-1000 g birth weight strata)
Number of subjects: 107
Study: 12686409

Group type: EXPERIMENTAL
Intervention: Men with RR-MS
Number of subjects: 47

Group type: COMPARATOR
Intervention: Women with RR-MS
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Females with RR-MS
Number of subjects: 47

Group type: COMPARATOR
Intervention: Males with RR-MS
Number of subjects: 47
Study: 11078264

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 130
Study: 8836781

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 65

Group type: COMPARATOR
Intervention: Local anaesthesia with sedation analgesia
Number of subjects: 65
Study: 1605596

Group type: EXPERIMENTAL
Intervention: Ofloxacin 200 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ofloxacin 400 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 6383998

Group type: EXPERIMENTAL
Intervention: Continuous intravenous administration of vasopressin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sengstaken‐Blakemore balloon tamponade
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall mortality in vasopressin group
Number of subjects: 37

Group type: COMPARATOR
Intervention: Overall mortality in tamponade group
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Uncontrolled bleeding mortality
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Complications of treatment mortality
Number of subjects: 37
Study: 30895583

Group type: EXPERIMENTAL
Intervention: Prophylactic pancreatic duct stenting (PPDS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 24
Study: 29181814

Group type: EXPERIMENTAL
Intervention: Working memory training after memory retrieval
Number of subjects: 0

Group type: COMPARATOR
Intervention: Working memory training prior to memory retrieval (Control)
Number of subjects: 0
Study: 27823685

Group type: EXPERIMENTAL
Intervention: Thoracic endovascular aortic repair (TEVAR)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conservative (medical) management
Number of subjects: 114
Study: 25091714

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100,000-U bolus intramuscularly plus 50,000 U orally weekly)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Asthma controllers (budesonide or budesonide plus formoterol)
Number of subjects: 130
Study: 22762173

Group type: EXPERIMENTAL
Intervention: Ferric Sulphate (FS)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 93
Study: 20522283

Group type: EXPERIMENTAL
Intervention: Volar-dorsal splinting (VDS)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Circumferential casting (CC)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Modified sugar-tong splinting (MST)
Number of subjects: 101

Group type: COMPARATOR
Intervention: All groups (CC, VDS, MST)
Number of subjects: 101
Study: 17984125

Group type: EXPERIMENTAL
Intervention: Malaria-specific T-cell responses
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Presence of T cells
Number of subjects: 117
Study: 16485863

Group type: EXPERIMENTAL
Intervention: Traveling Salesman Problem (TSP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Mini-Mental State Examination (MMSE)
Number of subjects: 45
Study: 11876600

Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT) with pullulan‐conjugated antigen (CS‐560)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (non-IT)
Number of subjects: 23
Study: 10992846

Group type: EXPERIMENTAL
Intervention: Deep topical fornix nerve block anaesthesia (DTFNBA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Peribulbar nerve block
Number of subjects: 120
Study: 9001651

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (ACV) 5‐80 mg/kg daily in four divided doses
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no ACV)
Number of subjects: 65
Study: 1483856

Group type: EXPERIMENTAL
Intervention: Vigabatrin (2 g/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Vigabatrin (dose titration up to 4 g/day)
Number of subjects: 101
Study: 4006263

Group type: EXPERIMENTAL
Intervention: Topical phenylpropanolamine (PPA) 25 mg/ml
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31306399

Group type: EXPERIMENTAL
Intervention: Inactivated quadrivalent influenza vaccine (IIV4)
Number of subjects: 12018

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12018
Study: 29543568

Group type: EXPERIMENTAL
Intervention: PBL health literacy program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 0
Study: 27576846

Group type: EXPERIMENTAL
Intervention: HDM2 inhibitor SAR405838
Number of subjects: 0
Study: 25065489

Group type: EXPERIMENTAL
Intervention: Buprenorphine pharmacotherapy and behavioral treatment
Number of subjects: 179
Study: 23751902

Group type: EXPERIMENTAL
Intervention: Shared care model with one tertiary appointment followed by up to 11 general practice consultations over one year, supported by web-based software.
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 118
Study: 20151996

Group type: EXPERIMENTAL
Intervention: Low carbohydrate Mediterranean diet (LCM)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet (TM)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: 2003 American Diabetic Association diet (ADA)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 259
Study: 17957000

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CrM) supplementation (loading phase, 20 g/day x 3 days; maintenance phase, 5 g/day x 7 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CrM) supplementation
Number of subjects: 12
Study: 15685069

Group type: EXPERIMENTAL
Intervention: Painful osteoarthritis of the knees
Number of subjects: 17

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 17
Study: 12855261

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) and folinic acid (FUFA) plus gemcitabine (GEM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) and folinic acid (FUFA)
Number of subjects: 0
Study: 10624435

Group type: EXPERIMENTAL
Intervention: MTI photoscreener
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cycloplegic refraction
Number of subjects: 38
Study: 7731108

Group type: EXPERIMENTAL
Intervention: recombinant growth hormone (r‐hGH) at a dose of 0.5 IU/kg/week
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: recombinant growth hormone (r‐hGH) at a dose of 1.0 IU/kg/week
Number of subjects: 27
Study: 2289410

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600mg twice daily
Number of subjects: 4081

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4081
Study: 6172073

Group type: EXPERIMENTAL
Intervention: Dextranomer (Debrisan)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Streptokinase-streptodornase (Varidase)
Number of subjects: 84
Study: 31152468

Group type: EXPERIMENTAL
Intervention: Observation group (BMI > 28 kg/m2)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (normal BMI)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: BMI, adiponectin, and leptin
Number of subjects: 122
Study: 28152330

Group type: EXPERIMENTAL
Intervention: Early KMC
Number of subjects: 160

Group type: COMPARATOR
Intervention: Late KMC
Number of subjects: 160
Study: 24916951

Group type: EXPERIMENTAL
Intervention: 3-month exercise intervention (160 min/week of moderate intensity aerobic walking, twice weekly resistance training with resistance bands, and six discussion groups)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 3-month exercise intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 24370303

Group type: EXPERIMENTAL
Intervention: Tetrandrine (100 mg) twice a day + Acetylcysteine effervescent tablets (600 mg) twice a day
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine therapy (anti-inflammatory, antitussive, and antiasthmatic drugs)
Number of subjects: 96
Study: 21385365

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy plus standard wound care
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard wound care only
Number of subjects: 118
Study: 19290718

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 172
Study: 16815864

Group type: EXPERIMENTAL
Intervention: Continuous treatment with celecoxib 200 mg once daily
Number of subjects: 123

Group type: COMPARATOR
Intervention: Intermittent treatment with celecoxib 200 mg once daily
Number of subjects: 123
Study: 15076811

Group type: EXPERIMENTAL
Intervention: SMART
Number of subjects: 1431

Group type: COMPARATOR
Intervention: ASMP
Number of subjects: 1431
Study: 11889277

Group type: EXPERIMENTAL
Intervention: Safer Choices educational program
Number of subjects: 3869
Study: 9624744

Group type: EXPERIMENTAL
Intervention: Generic counselling (up to six 50-minute sessions)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Usual GP care
Number of subjects: 162
Study: 8124176

Group type: EXPERIMENTAL
Intervention: Journeys to places to play outdoors (boys)
Number of subjects: 5334

Group type: EXPERIMENTAL
Intervention: Trip to school (younger pupils aged 11-12)
Number of subjects: 5334

Group type: EXPERIMENTAL
Intervention: Trip to school (poorer children)
Number of subjects: 5334

Group type: EXPERIMENTAL
Intervention: Accompaniment by an adult (poorer children)
Number of subjects: 5334
Study: 2682474

Group type: EXPERIMENTAL
Intervention: Naloxone 4 mg i.v.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 47
Study: 911649

Group type: EXPERIMENTAL
Intervention: Nomifensine 75 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Desipramine 50 mg
Number of subjects: 0
Study: 31160472

Group type: EXPERIMENTAL
Intervention: Three-dimensional VR interactive game as a distraction
Number of subjects: 64
Study: 27252077

Group type: EXPERIMENTAL
Intervention: Improved Atta (IAtta) with nutritional and physical activity counseling
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group with nutritional and physical activity counseling only
Number of subjects: 63
Study: 26329916

Group type: EXPERIMENTAL
Intervention: UMEC/VI 62.5/25 µg
Number of subjects: 4647

Group type: EXPERIMENTAL
Intervention: UMEC 62.5 µg
Number of subjects: 4647

Group type: EXPERIMENTAL
Intervention: VI 25 µg
Number of subjects: 4647

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4647

Group type: EXPERIMENTAL
Intervention: ICS users
Number of subjects: 4647

Group type: EXPERIMENTAL
Intervention: Non-ICS users
Number of subjects: 4647

Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs)
Number of subjects: 4647
Study: 24135893

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg once daily
Number of subjects: 626

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 626
Study: 22572567

Group type: EXPERIMENTAL
Intervention: Adapalene gel used topically twice daily for 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: 2% ketoconazole cream used topically twice daily for 2 weeks
Number of subjects: 80
Study: 19235039

Group type: EXPERIMENTAL
Intervention: Broccoli intake (200 g)
Number of subjects: 20
Study: 17518698

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR; 25% restriction)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CR plus structured exercise (CR + EX)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD; 890 kcal/d diet until 15% weight loss)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (weight maintenance)
Number of subjects: 48
Study: 15485530

Group type: EXPERIMENTAL
Intervention: CO(2) laser treatment
Number of subjects: 123

Group type: COMPARATOR
Intervention: Glucantime treatment
Number of subjects: 123